RPGLIFENSERPG Life Sciences Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 15 Dec, 2025 · 15:27 IST

RPG Life Sciences board approves new CFO, sets up API subsidiary, approves API biz transfer

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.8%Reaction day
₹2307.00
prior close
₹2371.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+2.3% vs market
Pharmaceuticals peers, median of 155sector-0.1%+2.9% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.8+0.5+2.3-0.1+2.9
Next day
+0.2-0.1+0.4-0.6+0.9
2d
+1.4-1.0+2.5-1.3+2.7
3d
+0.3-1.3+1.7-1.4+1.8
4d
+1.5-0.1+1.6-0.6+2.1
5d
+1.3+1.3+0.1-0.0+1.4
1w
+2.4+0.8+1.6-0.1+2.5
15d
-0.0+1.5-1.6+0.7-0.8
1m
+0.3-3.0+3.3-2.8+3.1
2m
-14.7-2.8-12.0-4.7-10.1
3m
-16.7-12.4-4.3-10.9-5.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved: (1) Mr. Amol Lone appointed as new CFO from Dec 15, 2025. (2) Incorporation of wholly owned subsidiary RPG Active Pharma Limited for the API business. (3) Transfer of API business to the WOS as going concern for approximately Rs 50 crore. (4) Investment of up to Rs 105 crore in the WOS. The API segment contributed about 13.8% of FY25 revenue (Rs 90.24 crore). Transfer expected by March 31, 2026.

Likely market impact

API business hived into new WOS with Rs 105 crore investment commitment. New CFO also appointed. Transfer expected by March 31, 2026.